WireAugust 11, 2026 at 10:31 PM
Loading the next story…
The Trump administration finalized a regulatory change Tuesday that will cut off federal Medicaid reimbursements for puberty blockers, cross-sex hormones, and surgical procedures for minors experiencing gender dysphoria. The rule, issued by the Centers for Medicare and Medicaid Services, takes full effect October 13, with a six-month phase-out period for beneficiaries already receiving hormone therapies.
The policy explicitly prohibits states from claiming federal matching dollars for what the administration terms "sex-rejecting procedures." Seventeen states currently cover some degree of these interventions under Medicaid and the Children's Health Insurance Program. Those states must now either halt coverage, absorb the full financial burden with their own tax revenues, or face federal audit and penalty risks. The move aligns with a broader effort to scrutinize how Medicaid dollars—intended for the medically needy—are allocated.
"The administration acknowledged concerns that restricting funding could lead to increased utilization of mental health crisis services, but stated the goal is not fiscal savings. This admission warrants scrutiny given Medicaid's strained budgets and the need to prioritize proven, cost-effective care for core populations."
Administration officials cited a 2025 Department of Health and Human Services report and a United Kingdom review, both of which found weak evidence supporting the long-term efficacy of pediatric medical transition. Major American medical guilds, including the American Medical Association and the American Academy of Pediatrics, denounced the rule, claiming it contradicts established medical consensus. However, these same organizations frequently lobby for expanded federal reimbursement codes, creating a direct financial interest in the treatments they now defend as "medically necessary."
Psychotherapy related to gender dysphoria remains eligible for federal Medicaid funding under the rule. The policy does not affect care for adults, nor does it impose new restrictions on what services providers may offer using state-only funds. Rodrigo Heng-Lehtinen of the Trevor Project called the move a "dangerous attempt to prevent transgender and nonbinary young people from accessing care," though the regulation does not outlaw any procedure—it simply ends the federal subsidy for it.
The administration reportedly shelved a separate proposal that would have terminated Medicare funding for hospitals providing transition-related services. The finalized Medicaid rule represents the latest executive action attempting to redefine the boundaries of federally-funded healthcare, leaving state capitols to confront the direct fiscal and political consequences.